NYSE:MED
Medifast Inc.
Medifast Inc.'s revenue fell 36.0% in fiscal 2025 to $385.8M while operating margin fell to −3.7%, its lowest in 10 years. Free cash flow was $1.2M, 0.3% of revenue.Summary generated from Medifast Inc.'s SEC filings. Latest annual report filed Feb 17, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$385.8M
Revenue growth−36.0%
Revenue, 5-yr CAGR−16.2%
Gross margin71.3%
Operating margin−3.7%
Net margin−4.8%
ROICn/a
Return on equity−9.1%
Debt / equityn/a
Free cash flow$1.2M
FCF margin0.3%
Share count change+0.2%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1,526 | 1,599 | 1,072 | 602 | 386 |
| Operating income | 216 | 185 | 126 | 3 | −14 |
| Net income | 164 | 144 | 99 | 2 | −19 |
| Free cash flow | 60 | 178 | 141 | 17 | 1 |
Recent filings
- 4Insider transaction report
Sep 30, 2026 - 4Insider transaction report
Aug 28, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 3, 2026 - 8-KResults of operations and financial condition
Aug 3, 2026 - 8-KRegulation FD disclosure
Jul 17, 2026 - 8-KDirector or officer change
Jun 1, 2026 - 8-KDirector or officer change
May 26, 2026 - 10-QQuarterly report for the period ended Mar 31, 2026
May 4, 2026